Skip to Content
Stock Analyst Update

Sysco: Despite Profit Improvement, Shares Overpriced

Though we'll likely raise our fair value estimate by a dollar or two on the narrow-moat firm, we don't view the risk/reward opportunity as attractive.

Mentioned:

Profit improvement persisted for narrow-moat  Sysco (SYY) in the second quarter, as adjusted gross margins increased 55 basis points to 18.3% and adjusted operating margins edged up 47 basis points to nearly 4.1%. In light of this performance and the gains realized through the first half of a three-year cost-restructuring plan, which is slated to be completed by the end of fiscal 2018, management ticked up its operating income improvement target to $600 million-$650 million from at least $500 million previously.

While we intend to review the assumptions underlying our discounted cash flow model, incorporating the updated profit targets will marginally boost our long-term margin forecast beyond the 5% operating margins we had previously expected, which was about 100 basis points above the level generated in fiscal 2016, and probably likely bolster our $46 fair value estimate by $1-$2 per share. Even though the shares fell at a mid-single-digit rate after the earnings release, we don’t view the risk/reward opportunity as attractive, with Sysco still trading at a 10% premium to our valuation.

Despite the profit gains, top-line growth slipped 0.2% on an organic basis, constrained by intense competition in an environment of languishing restaurant traffic trends. While deflationary trends persist, with management calling out 1.8% food cost deflation in its U.S. broadline business, we believe this pressure could become more pronounced if food cost inflation emerges, particularly in the dairy, protein, and produce categories. We think Sysco would be forced to bear the brunt of any pronounced upticks in costs, hampering profits, or risk losing share. However, we're holding the line on our narrow moat rating, which is based on the firm’s expansive distribution scale (with sales more than 2 times its next-largest competitor), which enables it to leverage the high level of fixed costs that plague the industry.

Morningstar Premium Members gain exclusive access to our full analyst reports, including fair value estimates, bull and bear breakdowns, and risk analyses. Not a Premium Member? Get this and other reports immediately when you try Morningstar Premium free for 14 days.

Erin Lash does not own (actual or beneficial) shares in any of the securities mentioned above. Find out about Morningstar’s editorial policies.

Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.

We’d like to share more about how we work and what drives our day-to-day business.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters.

How we use your information depends on the product and service that you use and your relationship with us. We may use it to:

  • Verify your identity, personalize the content you receive, or create and administer your account.
  • Provide specific products and services to you, such as portfolio management or data aggregation.
  • Develop and improve features of our offerings.
  • Gear advertisements and other marketing efforts towards your interests.

To learn more about how we handle and protect your data, visit our privacy center.

Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.

To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.

Read our editorial policy to learn more about our process.